These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 28148701

  • 1. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B, Diamantopoulos AP, Høiberg HK, Soldal DM, Kavanaugh A, Haugeberg G.
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [Abstract] [Full Text] [Related]

  • 2. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
    Michelsen B, Diamantopoulos AP, Hammer HB, Soldal DM, Kavanaugh A, Haugeberg G.
    Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E, De Socio A, Perrotta FM.
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [Abstract] [Full Text] [Related]

  • 4. Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors.
    Lubrano E, Parsons WJ, Perrotta FM.
    J Rheumatol; 2016 May; 43(5):918-23. PubMed ID: 26980581
    [Abstract] [Full Text] [Related]

  • 5. Disparity between ultrasound and clinical findings in psoriatic arthritis.
    Husic R, Gretler J, Felber A, Graninger WB, Duftner C, Hermann J, Dejaco C.
    Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
    [Abstract] [Full Text] [Related]

  • 6. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM, Marchesoni A, Lubrano E.
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [Abstract] [Full Text] [Related]

  • 7. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
    Salaffi F, Ciapetti A, Carotti M, Gasparini S, Gutierrez M.
    Biomed Res Int; 2014 Feb; 2014():528105. PubMed ID: 24967375
    [Abstract] [Full Text] [Related]

  • 8. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G, Kilic E, Nas K, Kamanlı A, Tekeoglu İ.
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [Abstract] [Full Text] [Related]

  • 9. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
    Kenar G, Yarkan H, Zengin B, Can G, Birlik M, Önen F.
    Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
    [Abstract] [Full Text] [Related]

  • 10. Remission criteria and activity indices in psoriatic arthritis.
    Acosta Felquer ML, Ferreyra Garrott L, Marin J, Catay E, Scolnik M, Scaglioni V, Ruta S, Rosa J, Soriano ER.
    Clin Rheumatol; 2014 Sep; 33(9):1323-30. PubMed ID: 24820142
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Composite Measure Remission Targets in Psoriatic Arthritis.
    Farkas F, Ikumi N, Elmamoun M, Szentpetery A, FitzGerald O.
    J Rheumatol; 2021 Aug; 48(8):1272-1278. PubMed ID: 33722944
    [Abstract] [Full Text] [Related]

  • 12. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E, Husmark T, Alenius GM, Larsson PT, Teleman A, Geijer M, Lindqvist UR.
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [Abstract] [Full Text] [Related]

  • 13. Comparison of disease activity measures in early psoriatic arthritis in usual care.
    Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael JHLM, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M, for CICERO.
    Rheumatology (Oxford); 2019 Dec 01; 58(12):2251-2259. PubMed ID: 31211399
    [Abstract] [Full Text] [Related]

  • 14. Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
    Helliwell P, Coates LC, FitzGerald O, Nash P, Soriano ER, Elaine Husni M, Hsu MA, Kanik KS, Hendrikx T, Wu J, Kudlacz E.
    Arthritis Res Ther; 2018 Oct 29; 20(1):242. PubMed ID: 30373651
    [Abstract] [Full Text] [Related]

  • 15. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.
    Haugeberg G, Michelsen B, Kavanaugh A.
    RMD Open; 2020 May 29; 6(1):. PubMed ID: 32409518
    [Abstract] [Full Text] [Related]

  • 16. A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors.
    Chimenti MS, Triggianese P, Conigliaro P, Tonelli M, Gigliucci G, Novelli L, Teoli M, Perricone R.
    Clin Rheumatol; 2017 Oct 29; 36(10):2253-2260. PubMed ID: 28762060
    [Abstract] [Full Text] [Related]

  • 17. Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population.
    Łosińska K, Michelsen B, Kavanaugh A, Korkosz M, Haugeberg G.
    Scand J Rheumatol; 2024 Jan 29; 53(1):10-20. PubMed ID: 37656147
    [Abstract] [Full Text] [Related]

  • 18. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
    Helliwell PS, Deodhar A, Gottlieb AB, Boehncke WH, Xu XL, Xu S, Wang Y, Hsia EC, Gladman DD, Ritchlin CT.
    Arthritis Care Res (Hoboken); 2020 Nov 29; 72(11):1579-1588. PubMed ID: 31421033
    [Abstract] [Full Text] [Related]

  • 19. Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
    Haugeberg G, Michelsen B, Tengesdal S, Hansen IJW, Diamantopoulos A, Kavanaugh A.
    Arthritis Res Ther; 2018 Aug 02; 20(1):160. PubMed ID: 30071892
    [Abstract] [Full Text] [Related]

  • 20. Residual Disease Activity and Associated Factors in Psoriatic Arthritis.
    Lubrano E, Scriffignano S, Perrotta FM.
    J Rheumatol; 2020 Oct 01; 47(10):1490-1495. PubMed ID: 31676704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.